Clinical and Therapeutical Importance of HBV genotyping in Romania
2009

Clinical and Therapeutical Importance of HBV Genotyping in Romania

Sample size: 130 publication Evidence: moderate

Author Information

Author(s): Constantinescu I, Nedelcu F, Toader MA, Vasile D

Primary Institution: Centre for Immunogenetics and Virology, Fundeni Clinical Institute

Hypothesis

The study aimed to identify the circulating HBV genotypes in Romania and correlate them with clinical outcomes.

Conclusion

HBV genotyping is crucial for selecting appropriate antiviral therapy and understanding the clinical outcomes of HBV infections.

Supporting Evidence

  • HBV A genotype is associated with inactive carrier status.
  • HBV D genotype is the most common and linked to active infection and hepatocellular carcinoma.
  • Long-term chronic HBV infection often shows a mixture of A and D genotypes.

Takeaway

This study looked at 130 patients to find out which types of the hepatitis B virus are common in Romania and how they affect people's health.

Methodology

Patients were tested for various HBV markers, and HBV genotyping was performed using specific amplification and genotyping kits.

Participant Demographics

130 patients with varying stages of HBV infection, including asymptomatic carriers and those with chronic hepatitis and hepatocellular carcinoma.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication